Trinity Biotech plc Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.60 | -$0.60 | -$0.60 |
Q2 2024 | 1 | -$0.67 | -$0.67 | -$0.67 |
Q3 2024 | 1 | -$0.54 | -$0.54 | -$0.54 |
Q4 2024 | 1 | -$0.30 | -$0.30 | -$0.30 |
Q1 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
Q3 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
Q4 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
Q1 2026 | 1 | -$0.19 | -$0.19 | -$0.19 |
Q2 2026 | 1 | -$0.11 | -$0.11 | -$0.11 |
Q3 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
Q4 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
Trinity Biotech plc Earnings Date And Information
Trinity Biotech plc last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.55 earnings per share for the quarter, topping analysts' consensus estimates of $-0.65 by $0.1. The company had revenue of 15.15 M for the quarter and had revenue of 56.83 M for the year. Trinity Biotech plc has generated $-3 earnings per share over the last year ($-3.14 diluted earnings per share) and currently has a price-to-earnings ratio of -0.66. Trinity Biotech plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based on prior year's report dates.
Trinity Biotech plc Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/15/2024 | Q3 2024 | -$0.46 | $16.50 M | $15.15 M | ||
10/02/2024 | Q2 2024 | -$0.71 | $15.00 M | $15.84 M | ||
02/01/2024 | Q1 2024 | -$0.37 | $14.70 M | |||
04/30/2024 | Q4 2023 | -$0.72 | $13.43 M | |||
10/06/2023 | Q3 2023 | -$0.88 | $14.50 M | $14.68 M | ||
07/10/2023 | Q2 2023 | -$0.78 | $13.50 M | $13.90 M | ||
03/27/2023 | Q1 2023 | -$0.83 | $14.83 M | |||
11/04/2022 | Q4 2022 | -$1.32 | $18.04 M | |||
09/06/2023 | Q3 2022 | -$1.17 | $19.50 M | $19.50 M | ||
04/11/2022 | Q2 2022 | $0.07 | -$0.59 | -0.66 | $18.75 M | $18.46 M |
04/11/2022 | Q1 2022 | $0.07 | -$0.08 | -0.15 | $18.78 M | |
12/16/2021 | Q4 2021 | $0.40 | $19.53 M | |||
09/09/2021 | Q3 2021 | $0.06 | $24.25 M | $22.00 M | ||
05/27/2021 | Q2 2021 | -$0.19 | $24.00 M | $25.84 M | ||
05/27/2021 | Q1 2021 | $0.08 | $25.59 M | |||
04/30/2021 | Q4 2020 | -$2.40 | $32.77 M | |||
09/30/2020 | Q3 2020 | $0.35 | $28.00 M | $32.01 M | ||
06/30/2020 | Q2 2020 | -$0.35 | $13.00 M | $16.02 M | ||
03/31/2020 | Q1 2020 | $0.06 | -$0.53 | -0.59 | $21.18 M | |
06/15/2020 | Q4 2019 | -$5.58 | $21.32 M |
Trinity Biotech plc Earnings: Frequently Asked Questions
-
When is Trinity Biotech plc's earnings date?
Trinity Biotech plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates.
-
Did Trinity Biotech plc beat their earnings estimates last quarter?
In the previous quarter, Trinity Biotech plc (:TRIB) reported $-0.55 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.65 by $0.1.
-
How can I listen to Trinity Biotech plc's earnings conference call?
The conference call for Trinity Biotech plc's latest earnings report can be listened to online.
-
How can I read Trinity Biotech plc's conference call transcript?
The conference call transcript for Trinity Biotech plc's latest earnings report can be read online.
-
How much revenue does Trinity Biotech plc generate each year?
Trinity Biotech plc (:TRIB) has a recorded annual revenue of $56.83 M.
-
How much profit does Trinity Biotech plc generate each year?
Trinity Biotech plc (:TRIB) has a recorded net income of $56.83 M. Trinity Biotech plc has generated $-3.14 earnings per share over the last four quarters.
-
What is Trinity Biotech plc's price-to-earnings ratio?
Trinity Biotech plc (:TRIB) has a price-to-earnings ratio of -0.66 and price/earnings-to-growth ratio is -0.26.